Atriomx Health Announces $10 Million Series A Financing-Funds to Be Used for Development and Clinical Study

CareDx to Present New Heart Transplant Data at the International Society for Heart and Lung Transplantation Annual Meeting

Experts will present its latest heart research, which was accepted at the International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, set to take place between April 24-28, 2021.

Dermatology Experts Present Latest Information at AAD VMX 2021

The AAD VMX 2021, a virtual meeting experience taking place April 23-25, will feature the latest information on skin, hair, and nails, presented by world-renowned experts in the field of dermatology.

Global Surgical Equipment Market 2021-2025: Impact of COVID-19 on the Surgical Equipment Market and Elective Surgery

This research report presents an in-depth analysis of the surgical equipment market, including forecasted trends and sales through 2025 Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed in the report.

December 22, 2020

Atriomx Health, a Menlo Park, California-based developer of novel, non-invasive solutions for the detection and characterization of the underlying disease mechanisms of atrial fibrillation and other arrhythmias, announced today that it has secured a $10 million Series A financing.

Atriomx Health notes Ajax Health and Zeus Health will co-lead the Series A round, the proceeds of which will be used to fund initial development and clinical study of the company’s hardware, software, and algorithmic solutions.

“This financing will allow Atriomx to pursue the tremendous opportunity to transform the diagnosis and treatment of atrial fibrillation stemming from the application of novel AF detection and characterization capabilities to data that can be collected non-invasively,” said Duke Rohlen, CEO of Ajax Health and Zeus Health.

In conjunction with the Series A financing, Atriomx Health has appointed Mike Carter to serve as the company’s Chief Operating Officer. Mike brings experience productizing advanced algorithms from Kodiak Robotics, where he was a founding engineer and software lead.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles